Multi-platform molecular analysis of sarcomatoid renal cell carcinoma (sRCC)

Authors:

Thai H. Ho, Sherri Z. Millis, Dave Bryant, Zoran Gatalica, Sandeep Reddy, Melissa L. Stanton, Eric P. Castle, Richard W. Joseph, Nicholas J. Vogelzang

Background

Patients with sRCC have a have a poor prognosis and decreased likelihood of response to targeted therapy or IL-2. Predictive biomarkers of response are lacking in sRCC. We evaluated a cohort of RCC patients to identify potentially actionable recurrent molecular aberrations.

Download Publication